Cartesian Therapeutics
RNAC
RNAC
80 hedge funds and large institutions have $38M invested in Cartesian Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-7
Holders Change %
-8.05%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
25
Reduced
22
Closed
14
Calls
$8K
Puts
$1K
Net Calls
+$7K
Net Calls Change
-$80K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$5.33M |
| 2 |
EAM
Erste Asset Management
Vienna,
Austria
|
$2.16M |
| 3 |
Morgan Stanley
New York
|
$393K |
| 4 |
Millennium Management
New York
|
$149K |
| 5 |
State Street
Boston,
Massachusetts
|
$1.52M |
